News | August 21, 2024
Procter & Gamble Health reports Q4 sales at Rs. 277 Cr
The company recorded sales of Rs. 1,129 crore for the fiscal year ended June 30, 2024,
The company recorded sales of Rs. 1,129 crore for the fiscal year ended June 30, 2024,
Coveris’ security labels also work seamlessly with self-checkouts where around 80% of retail sales now typically occur
The approved product has an estimated market size of US$ 268 million for the twelve months ending June 2024, according to IQVIA
Innovative technologies and comprehensive services to strengthen Syntegon’s strategic growth
This strategic decision will unlock significant value for our scientific and industrial products business
EBITDA for the quarter stood at Rs 964 crore, representing an EBITDA margin of 24%
Investing considerably in production capacity for medical device packaging at its Rohrdorf and Halle sites in Germany
10th edition of the event is scheduled to be held during May 30-June 1 at Hitex, Hyderabad
A game changing solution for the pharmaceutical industry
The WHO GMP approved vertically integrated ONCOLOGY unit of SAKAR has been selling products nationally since few quarters
Subscribe To Our Newsletter & Stay Updated
